Report: Bosnian Serb genocide detainee Mladic in hospital

October 11, 2011 12:16


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

BELGRADE - Bosnian Serb war crimes suspect Ratko Mladic, awaiting trial in The Hague, has been admitted to hospital suffering from pneumonia, his lawyer said on Tuesday.

The Yugoslav war crimes tribunal, where the former general faces genocide and war crimes charges over the 1992-1995 Bosnia war, confirmed Mladic was receiving medical treatment but said it could not reveal what for.

Mladic, 69, has frequently complained of ill health, most recently last week, since his arrest and extradition from Serbia in May.

Mladic's Belgrade lawyer, Milos Saljic, told Reuters the tribunal had informed him on Monday that Mladic had been transferred to hospital, "apparently because of pneumonia."

He said he had no further details.

Related Content

Breaking news
August 21, 2018
Russia accuses UK of trying to foist its Russia policies on the EU, U.S.